About UsMy AccountNo items in your cart
Find Articles by Publication


Repligen claims patent suit on B-MS' Orencia.(Repligen Corp.)(Bristol-Myers Squibb Co.)(Brief Article)
Publication Date: 16-JAN-06
Publication Title: Pharma Marketletter
Format: Online
Company: Repligen Corp.; Bristol-Myers Squibb Co.
Author:

Read this article now
Try Goliath Business News – FREE! 
You can view this article PLUS...

  • Over 5 million business articles
  • Hundreds of the most trusted magazines, newswires, and journals (see list)
  • Premium business information that is timely and relevant
  • Unlimited Access

Now for a Limited Time, try Goliath Business News
Free for 7 Days!

Tell Me More   Terms and Conditions

Purchase this article for $4.95

Description
US drugmaker Repligen and the University of Michigan have jointly filed a complaint against drug major Bristol-Myers Squibb in the District Court for the Eastern District of Texas for infringement of a US patent entitled Methods of Treating Autoimmune Disease via CTLA4-Ig, which covers methods of using this immunoglobin...



More articles from Pharma Marketletter
AZD6244 falls short in Ph II skin cancer study., 07-JAN-08
US survey claims drug samples denied to poor., 07-JAN-08
UK's fraud probe of AZ and GSK deals in Iraq., 07-JAN-08

Looking for additional articles?
Click here to search our database of over 3 million articles.

Username:

Password:
Forgot your password?



Home

Company Profiles

Industry Information

Industry & Market Reports

Business News

Business Development Resources

Business Leads

Business Directories

Business Management Resources

Business Plans

Business Encyclopedias

Online Courses

U.S. Job Search
Advertising, Refund Policy, Contact Us, Site Map, Add to del.icio.us, Customer Service, How to Buy, Frequently Asked Questions

Use of the Goliath service and this Web site constitutes acceptance of our Terms & Conditions and Privacy Policy.

Copyright © 2008, The Gale Group, a part of Cengage Learning, All Rights Reserved